NDC 86101-079-52 - Methimazole
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86101-079
- Requested NDC
- 86101-079-52
- Package NDCs from labels
- 86101-079-52, 86101-079-53
- Manufacturer
- FELIX PHARMACEUTICALS PRIVATE LIMITED
- Effective date
- 2026-08-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methimazole - FELIX PHARMACEUTICALS PRIVATE LIMITED | FELIX PHARMACEUTICALS PRIVATE LIMITED | 2026-08-25 | Prescription Animal Drug Label |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | f74a8e69-79a1-4061-b42f-447e0780c04f | 2025-05-13 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | 94d2e57b-685f-4cfd-a5a5-129e869c794c | 2025-04-24 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | a86f51a6-1ab8-48c2-a4fc-2439e9986d45 | 2025-04-24 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Rising Pharma Holdings, Inc. | 289ec852-176e-41aa-9f9a-b1f9b4196771 | 2025-03-06 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | American Health Packaging | ca252851-32f2-4eb9-b9f5-82029f0e8c20 | 2024-12-30 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | d003a93d-da08-4993-bb72-700342ca6e65 | 2024-12-24 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Golden State Medical Supply, Inc. | 4eff3321-2fce-4bab-94af-7b16e333beed | 2024-09-24 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | NORTHSTAR RX LLC | 923fec30-90fd-4bd5-beb3-f2ca4fc171ee | 2024-06-28 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Upsher-Smith Laboratories, LLC | 2185e6e0-7c21-4348-a7b4-d898f50a0184 | 2024-03-22 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Bionpharma Inc. | 141a91d5-b56e-06d6-e063-6394a90a11ba | 2024-03-20 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | e03d32dd-878f-43ee-b8c2-3adad98bf66c | 2024-02-21 | Warnings, Adverse reactions | 554Z48XN5E |
| methimazole | METHIMAZOLE | SQUARE PHARMACEUTICALS PLC. | 33e065a1-dd4e-43f9-a841-f96e633fc850 | 2024-02-20 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | 381052c4-891c-4ae4-b63e-65229126cbca | 2023-11-10 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | 3ca961ca-cbf2-4a73-8c81-4205e01b2695 | 2023-11-08 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | A-S Medication Solutions | 87eb663e-5dd3-4a7a-8b28-7e19c5ad1173 | 2023-06-29 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | c511344b-cc7f-499b-bb21-5b2312ff311e | 2023-02-20 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Bryant Ranch Prepack | 6bdf42f6-0ce6-4e05-8962-0019fc7c65a2 | 2023-02-17 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Strides Pharma Science Limited | 0f5fb0a4-feb9-4b86-9a93-b2c84cfc082f | 2022-04-22 | Warnings, Adverse reactions | 554Z48XN5E |
| Methimazole | METHIMAZOLE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 8c3a9aaa-cdde-404b-9af6-5a88ef649aac | 2022-03-24 | Warnings, Adverse reactions | 554Z48XN5E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.